Literature DB >> 14976381

Viable infectious cell sorting in a BSL-3 facility.

Stephen P Perfetto1, David R Ambrozak, Mario Roederer, Richard A Koup.   

Abstract

With the increase in demand for high-speed cell sorting of viable infectious and now therapeutic cell samples, safety concerns for the protection of flow cytometer operators have increased. This chapter describes a quick, sensitive, and reproducible procedure to assure sample containment before sorting these samples. This procedure includes aerosol containment, physical barriers, environmental controls, and personal protection. An aerosol management system produces a negative pressure within the sort chamber where aerosols are vacuumed directly into a HEPA filter. Physical barriers include the manufacturer's standard plastic shield and panels. The flow cytometer is contained in a BSL-3 laboratory for maximum environmental control and the operator is protected using a respiratory system. Containment is measured using highly fluorescent Glo-Germ particles under the same conditions as the cell sort but with the sorter adjusted to produce large amounts of aerosols. These aerosols are collected by a vacuum air sampling system for 10 min in three locations onto a glass slide and examined microscopically. With this system in place, aerosol containment can be measured quickly and efficiently, therefore reducing the risk to the operator when sorting viable infectious cells.

Mesh:

Substances:

Year:  2004        PMID: 14976381     DOI: 10.1385/1-59259-773-4:419

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

Review 1.  Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trials.

Authors:  D L DiGiusto; L J N Cooper
Journal:  Cytotherapy       Date:  2007       Impact factor: 5.414

Review 2.  Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures.

Authors:  Tjeerd G Kimman; Eric Smit; Michèl R Klein
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

3.  Amine-reactive dyes for dead cell discrimination in fixed samples.

Authors:  Stephen P Perfetto; Pratip K Chattopadhyay; Laurie Lamoreaux; Richard Nguyen; David Ambrozak; Richard A Koup; Mario Roederer
Journal:  Curr Protoc Cytom       Date:  2010-07

4.  Principles Governing Establishment versus Collapse of HIV-1 Cellular Spread.

Authors:  Jason M Hataye; Joseph P Casazza; Katharine Best; C Jason Liang; Taina T Immonen; David R Ambrozak; Samuel Darko; Amy R Henry; Farida Laboune; Frank Maldarelli; Daniel C Douek; Nicolas W Hengartner; Takuya Yamamoto; Brandon F Keele; Alan S Perelson; Richard A Koup
Journal:  Cell Host Microbe       Date:  2019-11-21       Impact factor: 21.023

5.  An Easy to Implement Approach for Laboratories to Visualize Particle Spread During the Handling and Analysis of Drug Evidence.

Authors:  Edward Sisco; Matthew E Staymates; Amber Burns
Journal:  Forensic Chem       Date:  2020

6.  Detection and Sorting of Extracellular Vesicles and Viruses Using nanoFACS.

Authors:  Aizea Morales-Kastresana; Joshua A Welsh; Jennifer C Jones
Journal:  Curr Protoc Cytom       Date:  2020-12

7.  Labeling Extracellular Vesicles for Nanoscale Flow Cytometry.

Authors:  Aizea Morales-Kastresana; Bill Telford; Thomas A Musich; Katherine McKinnon; Cassandra Clayborne; Zach Braig; Ari Rosner; Thorsten Demberg; Dionysios C Watson; Tatiana S Karpova; Gordon J Freeman; Rosemarie H DeKruyff; George N Pavlakis; Masaki Terabe; Marjorie Robert-Guroff; Jay A Berzofsky; Jennifer C Jones
Journal:  Sci Rep       Date:  2017-05-12       Impact factor: 4.379

8.  Validation of RNA-based molecular clonotype analysis for virus-specific CD8+ T-cells in formaldehyde-fixed specimens isolated from peripheral blood.

Authors:  David van Bockel; David A Price; Tedi E Asher; Vanessa Venturi; Kazuo Suzuki; Kristina Warton; Miles P Davenport; David A Cooper; Daniel C Douek; Anthony D Kelleher
Journal:  J Immunol Methods       Date:  2007-08-09       Impact factor: 2.303

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.